Study of the Epitope Mapping and Igg Sub-Classes of Anti-Factor VIII Antibodies in Patients with Haemophilia A

published by Damascus University in 2014 in Medicine and research's language is العربية Download

Abstract in English

Background& Objective: The development of inhibitors (Antibody against factor VIII ant-FVIII) is currently one of the major complications for the treatment of patients with hemophilia A, The only effective treatment available today when they appear is Immune Tolerance Induction ITI, There is no to the present any laboratory predictor of response to this worrying and expensive treatment. This research aims to study the epitope mapping and identification of IgG sub-classes of factor FVIII inhibitors to study the immune response against factor VIII in patients with hemophilia A.

References used

Lollar, P. Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX. Thromb Haemost 2004,2, 1082–1095

Collins PW, Percy CL. Advances in the uunderstanding of acquired haemophilia A : implications for clinical practice, Br. J. Haematol., 2009, 148, 183-194

Mannucci P. Autoimmune haemophilia, Blood Transfus.2008, 6, 6-7

Reipert, B.M., van Helden, P.M., Schwarz, H.P. & Hausl, C. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors. Br. J. Haematol 2007, 136, 12–25

Brackmann H.H, Gormsen J. Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder. Lancet 1977,2, 933

Download